Rybelsus outperformed Januvia and Jardiance in trials on measures like blood glucose reductions, so there is a case to be made for premium pricing. Meanwhile, Novo Nordisk was concerned that if it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback